Straumann Holding AG (SAUHY)
USD 12.56
(2.95%)
USD 12.56
(2.95%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.41 Billion CHF | 3.92% |
| 2022 | 2.32 Billion CHF | 14.78% |
| 2021 | 2.02 Billion CHF | 41.8% |
| 2020 | 1.42 Billion CHF | -10.67% |
| 2019 | 1.59 Billion CHF | 17.06% |
| 2018 | 1.36 Billion CHF | 22.61% |
| 2017 | 1.11 Billion CHF | 21.21% |
| 2016 | 917.51 Million CHF | 14.89% |
| 2015 | 798.6 Million CHF | 12.44% |
| 2014 | 710.27 Million CHF | 4.46% |
| 2013 | 679.92 Million CHF | -0.92% |
| 2012 | 686.25 Million CHF | -1.06% |
| 2011 | 693.58 Million CHF | -5.97% |
| 2010 | 737.64 Million CHF | 0.17% |
| 2009 | 736.36 Million CHF | -5.44% |
| 2008 | 778.7 Million CHF | 9.12% |
| 2007 | 713.65 Million CHF | 19.1% |
| 2006 | 599.2 Million CHF | 17.59% |
| 2005 | 509.55 Million CHF | 21.24% |
| 2004 | 420.29 Million CHF | 22.23% |
| 2003 | 343.86 Million CHF | 25.09% |
| 2002 | 274.89 Million CHF | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.27 Billion CHF | 6.55% |
| 2023 Q4 | 1.19 Billion CHF | -1.8% |
| 2023 Q2 | 1.21 Billion CHF | 6.52% |
| 2023 FY | 2.41 Billion CHF | 3.92% |
| 2022 Q4 | 1.14 Billion CHF | -3.05% |
| 2022 Q2 | 1.17 Billion CHF | 13.69% |
| 2022 FY | 2.32 Billion CHF | 14.78% |
| 2021 Q4 | 1.03 Billion CHF | 5.17% |
| 2021 FY | 2.02 Billion CHF | 41.8% |
| 2021 Q2 | 985.48 Million CHF | 20.07% |
| 2020 Q2 | 605.08 Million CHF | -25.86% |
| 2020 FY | 1.42 Billion CHF | -10.67% |
| 2020 Q4 | 820.76 Million CHF | 35.64% |
| 2019 Q2 | 780.03 Million CHF | 14.36% |
| 2019 FY | 1.59 Billion CHF | 17.06% |
| 2019 Q4 | 816.19 Million CHF | 4.64% |
| 2018 FY | 1.36 Billion CHF | 22.61% |
| 2018 Q2 | 681.45 Million CHF | 19.83% |
| 2018 Q4 | 682.1 Million CHF | 0.09% |
| 2017 Q4 | 568.68 Million CHF | 4.65% |
| 2017 Q2 | 543.42 Million CHF | 19.1% |
| 2017 FY | 1.11 Billion CHF | 21.21% |
| 2016 Q2 | 461.24 Million CHF | 15.28% |
| 2016 FY | 917.51 Million CHF | 14.89% |
| 2016 Q4 | 456.27 Million CHF | -1.08% |
| 2015 Q4 | 400.11 Million CHF | 0.41% |
| 2015 Q2 | 398.48 Million CHF | 13.48% |
| 2015 FY | 798.6 Million CHF | 12.44% |
| 2014 Q4 | 351.14 Million CHF | -2.22% |
| 2014 FY | 710.27 Million CHF | 4.46% |
| 2014 Q2 | 359.13 Million CHF | 10.45% |
| 2013 Q2 | 354.77 Million CHF | 0.0% |
| 2013 FY | 679.92 Million CHF | -0.92% |
| 2013 Q4 | 325.14 Million CHF | -8.35% |
| 2012 Q4 | - CHF | 0.0% |
| 2012 FY | 686.25 Million CHF | -1.06% |
| 2011 Q4 | - CHF | 0.0% |
| 2011 FY | 693.58 Million CHF | -5.97% |
| 2010 FY | 737.64 Million CHF | 0.17% |
| 2010 Q4 | - CHF | 0.0% |
| 2009 FY | 736.36 Million CHF | -5.44% |
| 2009 Q4 | - CHF | 0.0% |
| 2008 FY | 778.7 Million CHF | 9.12% |
| 2007 FY | 713.65 Million CHF | 19.1% |
| 2006 FY | 599.2 Million CHF | 17.59% |
| 2005 FY | 509.55 Million CHF | 21.24% |
| 2004 FY | 420.29 Million CHF | 22.23% |
| 2003 FY | 343.86 Million CHF | 25.09% |
| 2002 FY | 274.89 Million CHF | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -75470.692% |
| Ansell Limited | 1.61 Billion USD | -48.942% |
| Ansell Limited | 1.61 Billion USD | -48.942% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -1206.175% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1785705.042% |
| Psykey, Inc. | 419.29 Thousand USD | -575102.66% |
| ConvaTec Group Plc | 2.19 Billion USD | -9.927% |
| ConvaTec Group Plc | 2.14 Billion USD | -12.576% |
| Encision Inc. | 6.58 Million USD | -36521.048% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -132059.897% |
| LifePoint, Inc. | -18.5 Thousand USD | 13036959.459% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -35300.25% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -312311.788% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -244451.824% |
| Reflect Scientific, Inc. | 1.08 Million USD | -223184.735% |
| SmileDirectClub, Inc. | 470.74 Million USD | -412.343% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -28.863% |
| SheerVision, Inc. | 3.49 Million USD | -68820.791% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -173876.011% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -323593.687% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -2312663.346% |